Mainz Biomed N.V.
MYNZ
$3.07
-$0.15-4.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 12/31/2023 | 06/30/2023 | 03/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 186.60K | 186.60K | 214.80K | 248.90K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 186.60K | 186.60K | 214.80K | 248.90K | -- |
| Cost of Revenue | 58.70K | 58.70K | 80.00K | 100.10K | -- |
| Gross Profit | 127.90K | 127.90K | 134.70K | 148.80K | -- |
| SG&A Expenses | 3.14M | 3.14M | 4.73M | 4.96M | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.49M | 4.49M | 6.81M | 8.18M | -- |
| Operating Income | -4.31M | -4.31M | -6.59M | -7.93M | -- |
| Income Before Tax | -5.31M | -5.31M | -5.18M | -8.25M | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.31M | -5.31M | -5.18M | -8.25M | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.31M | -5.31M | -5.18M | -8.25M | -- |
| EBIT | -4.31M | -4.31M | -6.59M | -7.93M | -- |
| EBITDA | -4.12M | -4.12M | -6.32M | -7.88M | -- |
| EPS Basic | -3.86 | -3.86 | -10.86 | -22.13 | -- |
| Normalized Basic EPS | -2.01 | -2.01 | -7.72 | -- | -- |
| EPS Diluted | -3.86 | -3.86 | -10.86 | -22.13 | -- |
| Normalized Diluted EPS | -2.01 | -2.01 | -7.72 | -- | -- |
| Average Basic Shares Outstanding | 1.38M | 1.38M | 477.20K | 372.90K | -- |
| Average Diluted Shares Outstanding | 1.38M | 1.38M | 477.20K | 372.90K | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |